Hybrid systems, which combine paper and electronic components within a single GxP process, present unique data integrity challenges that require careful management. In a hybrid system, some records may be created electronically while others are maintained on paper, or electronic signatures may be applied to paper records. Regulatory agencies expect that the overall system ensures data integrity equivalent to a fully paper or fully electronic system.
What Are Hybrid Systems?
A hybrid system is any GxP process where electronic and paper records coexist and interact to create the complete record set. Common examples include electronic batch records that print paper copies for signature, or laboratory instruments that generate electronic data while manual observations are recorded on paper. The interfaces between paper and electronic components are where data integrity risks are highest.
Principles
The data integrity requirements of ALCOA+ apply to the entire record set regardless of the medium. In hybrid systems, the linkage between paper and electronic records must be maintained so that the complete record can be reconstructed. Organizations must define which medium is the original record and how the two components complement each other to form a complete, attributable, and accurate record.
Best Practices
Document the system architecture clearly, specifying the flow of data between paper and electronic components and identifying the original record for each data element. Implement controls to ensure that cross-references between paper and electronic records are maintained and reconcilable. Validate hybrid processes to demonstrate that data integrity is preserved across the transition points, and ensure that audit trails from the electronic components are available for review alongside the paper records.
Regulatory Requirements
21 CFR Part 11 applies to the electronic components of hybrid systems, while the paper components must comply with Good Documentation Practices. EU Annex 11 addresses computerized systems that may interact with paper processes, and ICH Q7 requires that hybrid systems be controlled to ensure data integrity. Regulatory inspectors will examine both components and their integration during audits.
Conclusion
Hybrid systems are a reality in most pharmaceutical organizations, particularly during the transition from paper to fully electronic processes. A clear understanding of the data flow and rigorous controls at the paper-electronic interface are essential for compliance. Organizations should have a strategy for migrating toward fully electronic systems where feasible to simplify data integrity management.
